CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 46 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $369,000 | +0.8% | 52,767 | 0.0% | 0.01% | +10.0% |
| Q1 2017 | $366,000 | +26.2% | 52,767 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $290,000 | +9.8% | 52,767 | 0.0% | 0.01% | +14.3% |
| Q3 2016 | $264,000 | -29.8% | 52,767 | -36.8% | 0.01% | -36.4% |
| Q2 2016 | $376,000 | +9.0% | 83,535 | +8.6% | 0.01% | -8.3% |
| Q1 2016 | $345,000 | -14.6% | 76,896 | 0.0% | 0.01% | -14.3% |
| Q4 2015 | $404,000 | -9.0% | 76,896 | 0.0% | 0.01% | -6.7% |
| Q3 2015 | $444,000 | +1.6% | 76,896 | +25.7% | 0.02% | +36.4% |
| Q2 2015 | $437,000 | +163.3% | 61,156 | +144.9% | 0.01% | +175.0% |
| Q1 2015 | $166,000 | – | 24,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |